Clinical

Our xTAG® and MultiCode™-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
 
Read More

Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
 
Read More

Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
 
Learn More

Luminex® Blog

The Faces of Luminex: Molly Frazier, Marketing

With Luminex’s large workforce and active marketing department, you might imagine that there are loads of ongoing projects at any one time. This could quickly lead to chaos if it weren’t for Molly Frazier, Copywriter & Marketing Coordinator, who has been keeping the trains running on time since joining the company in 2016. She earned her bachelor’s degree from Sam Houston State University.

Continue Reading >

xMAP® Technology Overview

 
Luminex xMAP® Technology Overview

 

xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.

Watch more videos >

Luminex on Twitter


RT @CDCFlu: Latest #FluView report shows #flu activity remains low across most of the country, although small increases have been reported:…
h J R
It's World Antibiotic Awareness Week. According to the CDC, about 2 million people in the U.S. contract drug-resist… https://t.co/F0nblGBeYb
h J R
From minimal orders during the summertime to bursting-at-the-seams capacity in peak #flu season, labs need to be ab… https://t.co/DyhjsE6gde
h J R

Latest News

November 5
Luminex Corporation Reports Third Quarter 2018 Financial Results

October 18
Luminex Corporation to Acquire MilliporeSigma’s Flow Cytometry Portfolio

October 15
Luminex Corporation Third Quarter Earnings Release Scheduled for November 5, 2018

September 11
Luminex Corporation Declares Third Quarter Cash Dividend

September 6
Luminex Corporation to Present at the Morgan Stanley 16th Annual Global Healthcare Conference

Events

xMAP® Connect Amsterdam
6-7 November
Amsterdam, Netherlands